Cancer Gene Therapy : Impact Factor & More
eISSN: 1476-5500pISSN: 0929-1903
Share this on:
Key Metrics
CiteScore 
8.4
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Cancer Research
SNIP
0.97
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Gene Therapy
Cancer Gene Therapy Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Gene Therapy
CLK3 regulates tumor angiogenesis by modulating HIF1α ubiquitination.
- 27 Jul 2026
- Cancer gene therapy
Targeting RAB27A-mediated small extracellular vesicle secretion via CRISPR-Cas9 negatively affects proliferation and metastasis in both in vitro and in vivo SCLC models.
- 20 Jul 2026
- Cancer gene therapy
CagA promotes gastric cancer stemness and metastasis via DNMT1-mediated epigenetic silencing of BEX1.
- 16 Jul 2026
- Cancer gene therapy
Retraction Note: Downregulation of SBF2-AS1 functions as a tumor suppressor in clear cell renal cell carcinoma by inhibiting miR-338-3p-targeted ETS1.
- 15 Jul 2026
- Cancer gene therapy
LD-associated signatures identified by perilipin-based proximity labeling proteomics reveal GNA14 as a therapeutic and prognostic target in renal cell carcinoma.
- 11 Jul 2026
- Cancer gene therapy
Inhibiting CXCL12/CXCR4 axis enhances T cell activity in gastric cancer.
- 11 Jul 2026
- Cancer gene therapy
CLK3 regulates tumor angiogenesis by modulating HIF1α ubiquitination.
- 27 Jul 2026
- Cancer gene therapy
Targeting RAB27A-mediated small extracellular vesicle secretion via CRISPR-Cas9 negatively affects proliferation and metastasis in both in vitro and in vivo SCLC models.
- 20 Jul 2026
- Cancer gene therapy
CagA promotes gastric cancer stemness and metastasis via DNMT1-mediated epigenetic silencing of BEX1.
- 16 Jul 2026
- Cancer gene therapy
Retraction Note: Downregulation of SBF2-AS1 functions as a tumor suppressor in clear cell renal cell carcinoma by inhibiting miR-338-3p-targeted ETS1.
- 15 Jul 2026
- Cancer gene therapy
LD-associated signatures identified by perilipin-based proximity labeling proteomics reveal GNA14 as a therapeutic and prognostic target in renal cell carcinoma.
- 11 Jul 2026
- Cancer gene therapy
Inhibiting CXCL12/CXCR4 axis enhances T cell activity in gastric cancer.
- 11 Jul 2026
- Cancer gene therapy
FAQs on Cancer Gene Therapy
How long has Cancer Gene Therapy been actively publishing? 
What is the publishing frequency of Cancer Gene Therapy?
How many articles did Cancer Gene Therapy publish last year?
What is the eISSN & pISSN for Cancer Gene Therapy?
What is Citescore for Cancer Gene Therapy?
What is SNIP score for Cancer Gene Therapy?
What is the SJR for Cancer Gene Therapy?
Who is the publisher of Cancer Gene Therapy?
